Back to Market Feed

Product Information

DIURIL 250 MG/5 ML ORAL SUSP is a brand product labeled by Salix Pharmaceuticals Inc., priced at $0.3062 per ML under NDC 65649031112. Its NADAC has been published 463 times since Nov 28, 2013.

FDA first approved this application before 1982.

DIURIL 250 MG/5 ML ORAL SUSP

CHLOROTHIAZIDE
$0.3062per ML

Strength

250 mg/5mL

NDC

65649031112

Classification

Brand

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

9/17/2025

Active Ingredients

CHLOROTHIAZIDE

Approval Type

New Drug (NDA)

FDA Application

NDA011870

FDA Approved

Before 1982

On Market Since

2/15/1962

Pharmacological Classes

Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for DIURIL 250 MG/5 ML ORAL SUSP has been published 463 times since Nov 28, 2013, and over the history we have for it it has risen 38.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3062 per ML
All-time high$0.3062 (Oct 1, 2025)
All-time low$0.2198 (Jun 18, 2014)
52-week high$0.3062
52-week low$0.2786
Median price$0.2782
Average price$0.2634
Largest weekly change+9.9% (Sep 24, 2025)
Weeks tracked463
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

+9.9%

3Y

+9.3%

5Y

+10.1%

All

+38.6%

Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CHLOROTHIAZIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

HEMICLOR 12.5 MG TABLET
Brand
50742028530•Ingenus Pharmaceuticals LLC
$0.9570
per EA
HEMICLOR 12.5 MG TABLET
Brand
50742028590•Ingenus Pharmaceuticals LLC
$0.9570
per EA
THALITONE 15 MG TABLET
Brand
70199001730•Casper Pharma LLC
$3.5373
per EA
INZIRQO 10 MG/ML ORAL SUSP
Brand
70954052210•ANI Pharmaceuticals, Inc.
$4.4572
per ML
MICARDIS HCT 80-25 MG TABLET
Brand
00597004237•Boehringer Ingelheim Pharmaceuticals Inc.
$4.4768
per EA
MICARDIS HCT 80-12.5 MG TABLET
Brand
00597004437•Boehringer Ingelheim Pharmaceuticals Inc.
$4.4802
per EA
MICARDIS HCT 40-12.5 MG TABLET
Brand
00597004337•Boehringer Ingelheim Pharmaceuticals Inc.
$4.4836
per EA
HYZAAR 50-12.5 TABLET
Brand
78206013901•Organon LLC
$5.0084
per EA
HYZAAR 50-12.5 TABLET
Brand
78206013902•Organon LLC
$5.0084
per EA
HYZAAR 100-12.5 TABLET
Brand
78206014001•Organon LLC
$6.8200
per EA

Frequently asked questions

What is the NADAC price of DIURIL 250 MG/5 ML ORAL SUSP?

The current National Average Drug Acquisition Cost (NADAC) for DIURIL 250 MG/5 ML ORAL SUSP, manufactured by Salix Pharmaceuticals Inc., is $0.3062 per ML (NDC 65649031112), effective Oct 1, 2025.

How has the price of DIURIL 250 MG/5 ML ORAL SUSP changed over time?

Over the history we have for it, the NADAC for DIURIL 250 MG/5 ML ORAL SUSP has risen 38.6%. It has been tracked across 463 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for DIURIL 250 MG/5 ML ORAL SUSP?

Since Nov 28, 2013, the NADAC for DIURIL 250 MG/5 ML ORAL SUSP has ranged from a low of $0.2198 (Jun 18, 2014) to a high of $0.3062 (Oct 1, 2025), with a median of $0.2782 per ML.

Are there cheaper alternatives to DIURIL 250 MG/5 ML ORAL SUSP?

No other NADAC-published product currently shares the active ingredient and strength of DIURIL 250 MG/5 ML ORAL SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DIURIL 250 MG/5 ML ORAL SUSP?

DIURIL 250 MG/5 ML ORAL SUSP (NDC 65649031112) is labeled by Salix Pharmaceuticals Inc., and CMS classifies it as a brand product.